<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yang P</submitter><funding>NIH/NCI</funding><funding>NCI NIH HHS</funding><funding>Black Beret Life Sciences</funding><pagination>1534735419840797</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6475842</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18</volume><pubmed_abstract>Biofield therapies have gained popularity and are being explored as possible treatments for cancer. In some cases, devices have been developed that mimic the electromagnetic fields that are emitted from people delivering biofield therapies. However, there is limited research examining if humans could potentially inhibit the proliferation of cancer cells and suppress tumor growth through modification of inflammation and the immune system. We found that human NSCLC A549 lung cancer cells exposed to Sean L. Harribance, a purported healer, showed reduced viability and downregulation of pAkt. We further observed that the experimental exposure slowed growth of mouse Lewis lung carcinoma evidenced by significantly smaller tumor volume in the experimental mice (274.3 ± 188.9 mm&lt;sup>3&lt;/sup>) than t</pubmed_abstract><journal>Integrative cancer therapies</journal><pubmed_title>Human Biofield Therapy and the Growth of Mouse Lung Carcinoma.</pubmed_title><pmcid>PMC6475842</pmcid><funding_grant_id>P30CA016672</funding_grant_id><funding_grant_id>P30 CA016672</funding_grant_id><funding_grant_id>R50 CA221675</funding_grant_id><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Coway T</pubmed_authors><pubmed_authors>Rhea PR</pubmed_authors><pubmed_authors>Harribance SL</pubmed_authors><pubmed_authors>Cohen L</pubmed_authors><pubmed_authors>Yang P</pubmed_authors><pubmed_authors>Gagea M</pubmed_authors><pubmed_authors>Chen D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Human Biofield Therapy and the Growth of Mouse Lung Carcinoma.</name><description>Biofield therapies have gained popularity and are being explored as possible treatments for cancer. In some cases, devices have been developed that mimic the electromagnetic fields that are emitted from people delivering biofield therapies. However, there is limited research examining if humans could potentially inhibit the proliferation of cancer cells and suppress tumor growth through modification of inflammation and the immune system. We found that human NSCLC A549 lung cancer cells exposed to Sean L. Harribance, a purported healer, showed reduced viability and downregulation of pAkt. We further observed that the experimental exposure slowed growth of mouse Lewis lung carcinoma evidenced by significantly smaller tumor volume in the experimental mice (274.3 ± 188.9 mm&lt;sup>3&lt;/sup>) than t</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jan-Dec</publication><modification>2026-07-13T07:13:47.653Z</modification><creation>2019-06-06T22:58:50Z</creation></dates><accession>S-EPMC6475842</accession><cross_references><pubmed>30947564</pubmed><doi>10.1177/1534735419840797</doi></cross_references></HashMap>